Gilead Sciences acquires promising HIV vaccine from Aelix Therapeutics
USA—Gilead Sciences has reinforced its leadership in HIV research by acquiring an experimental HIV...
Read More
Tag: Gilead Sciences
Gilead donates 5,100 remdesivir vials to combat Marburg Virus in Rwanda
RWANDA — Gilead Sciences, Inc., in partnership with Africa CDC and Rwanda’s Ministry of Health,...
Read More
EVA Pharma signs agreement with Gilead to expand access to HIV treatment
EGYPT—EVA Pharma has signed a nonexclusive, royalty-free voluntary licensing agreement with Gilead...
Read More
Gilead renews partnership with Cigalah to boost Saudi healthcare
SAUDI ARABIA — Gilead Sciences, an American biopharmaceutical business, has announced the renewal...
Read More
Gilead Sciences tops global philanthropy in HIV programs for second consecutive year
USA – Gilead Sciences, Inc. has once again secured the top position as the leading philanthropic...
Read More
Gilead Sciences, Emirates Oncology Society sign cancer research deal
UAE – Gilead Sciences, Inc., a renowned research-based biopharmaceutical company, has struck a...
Read More
Gilead joins forces with Tentarix Biotherapeutics in an innovative research odyssey
USA —In a trailblazing move that underscores its commitment to cutting-edge biotechnology, Gilead...
Read More
Gilead Sciences expands therapeutic horizons with US$35 million investment in Arcus Biosciences
USA — Gilead Sciences, a prominent biopharmaceutical company, has once again demonstrated its...
Read More
Gilead Sciences taps Vitor Papao as the new General Manager of its Middle East operations
UAE – Vitor Papao has taken over as the new General Manager of Gilead Sciences’ Middle East...
Read More
Gilead Sciences funds HIV/AIDS prevention programme in Uganda
UGANDA – Gilead Sciences, Inc., an American biopharmaceutical company, is funding a new HIV/AIDS...
Read More
LATEST DIGITAL MAGAZINE
